Little is known about the effect of recent advances, particularly the approval of venetoclax in late 2018, in acute myeloid leukemia (AML) treatment on racial/ethnic disparities in survival outcomes. Therefore, researchers performed a retrospective cohort study of patients with newly diagnosed AML using data from the Flatiron Health database, a nationwide database derived from electronic health records in which data are deidentified. Results were published in Blood Advances. ...
Disparities in Blood Cancers
Advertisement
Researchers investigated whether socioeconomic status and healthcare resource availability affect OS in multiple myeloma.
Persistent or newly developed lymphopenia after diagnosis was also linked to an increased risk of mortality.
Individuals living in lower-income areas experience disproportionately higher rates of late-stage diagnoses and mortality
responding physicians (92%) reported that prior authorization causes treatment delays for their patients
Area Deprivation Index was associated with overall survival in both Black and Hispanic patients.
Black, Hispanic, and Asian patients were underrepresented in trials compared with national lymphoma data.
Families reported the direct cash support program offered them the “ability to spend more time at their child’s ...
Despite delays to infusion, response rates to CAR-T were comparable across racial groups.
Advertisement
Expert Interviews
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.